Blog

• posted: May 01, 2023

(HealthDay News) — A new clinical trial strengthens the case that ketamine — once famous as a club drug — can rapidly ease suicidal thoughts. Researchers found that among 156 adults Read More

• posted: May 01, 2023

Researchers at Cincinnati Children’s Hospital Medical Center have concluded that intranasal ketamine is as effective as intranasal fentanyl for the relief of pain from acute extremity injury in children. The Read More

• posted: May 01, 2023

The results of a new clinical trial with ketamine were published in Nature’s Molecular Psychiatry journal.  Researchers conducted a double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant Read More

• posted: May 01, 2023

The National Institute of Mental Health (NIMH) issued a highlight on ketamine for treating depression. The most commonly used antidepressants are largely variations on a theme; they increase the supply within synapses of Read More

• posted: May 01, 2023

Researchers from the University of Minnesota and The Mayo Clinic found that ketamine caused an average decrease of 42% on the Children’s Depression Rating Scale(CDRS)—the most widely used rating scale in Read More

• posted: May 01, 2023

Researchers at Yale published a new study titled “Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital” in Clinical Psychiatry.  In late 2014, Yale began Read More

• posted: May 01, 2023

CNN featured a segment on the use of ketamine for treating suicidal ideation–a novel, off-label use for ketamine that is currently being explored in human clinical trials.  The segment featured Dr. Read More

• posted: May 01, 2023

Neuropathic pain is notoriously difficult to treat.  Patients are often treated as regular chronic pain patients and many resort to opioids to manage extreme levels of pain. Neuropathic pain can Read More

• posted: May 01, 2023

Australian researchers completed the world’s first randomized control trial (RCT), assessing the efficacy and safety of ketamine as a treatment for depression in elderly patients. In this double-blind, controlled, multiple-crossover study Read More

• posted: May 01, 2023

It’s been more than two years now since the former director of the National Institute of Mental Health wrote about the use of intravenous ketamine for the treatment of mental Read More

• posted: May 01, 2023

PTSD Treatment – Ketamine is a novel treatment for several psychiatric disorders including: Major Depressive Disorder, Bipolar Depression, Postpartum Depression, Obsessive-Compulsive Disorder (OCD), and Posttraumatic Stress Disorder or PTSD.  It Read More

• posted: May 01, 2023

Good news for patients suffering from Chronic Migraine or new daily persistent headache.  A retrospective review of 77 patients who underwent administration of intravenous, subanesthetic ketamine was conducted by investigators Read More

• posted: May 01, 2023

Complex Regional Pain Syndrome (CRPS) is an extremely painful neuropathic pain condition that is notoriously hard to treat. At present, there are no FDA-approved medications that are indicated for treating Read More

• posted: May 01, 2023

Depression affects approximately one in five Americans and while most people respond to antidepressant medications, 1/3 will not. However, emerging research and countless case studies have shown that intravenous (IV) Read More

• posted: May 01, 2023

Ticks have arguably the most dangerous bite to humans of any species. Our warming climate will only make things worse as ticks become able to breed all year long, and Read More

• posted: May 01, 2023

Ketamine is a long known anesthetic agent that is still used for induction anesthesia in medicine today. It is also used off label for the treatment of various treatment-resistant diseases Read More